Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation

Go back to Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
EATON VANCE OHIO MUNI INCOME T (NASDAQ: EVO) Delayed: 2.84 --0 (-0%)
Previous Close $2.84    52 Week High $16.39 
Open $2.84    52 Week Low $13.22 
Day High $2.84    P/E N/A 
Day Low $2.84    EPS $-1.61 
Volume 1,018